Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 25 Aug 2026 for Cellebrite DI Ltd., €42k. Read the official filing
Filing timeline
BuySaleDavid Nicholas Gee
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Nicholas Gee: trading record in brief
All filings by David Nicholas Gee on record concern Cellebrite DI Ltd. We count 6 filings; the first trade dates from 12 May 2026 and the latest from 24 August 2026.
Every open-market trade on record is a sale: 6 sales worth €133k.
The latest filing, published on 25 August 2026, reports an open-market sale of €42k in Cellebrite DI Ltd. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Nicholas Gee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
4,323 shares@ US$11.36050.0017% mcap31.6% of flowOrdinary shares, par value NIS 0.00001SEC:0001628280-26-058874:0
2,198 shares@ US$11.24160.0009% mcap23.2% of flowOrdinary shares, par value NIS 0.00001SEC:0001628280-26-058628:0
230 shares@ US$16.06780.0001% mcap4.6% of flowOrdinary shares, par value NIS 0.00001SEC:0001628280-26-056491:0
2,243 shares@ US$13.100.0011% mcap36.6% of flowOrdinary shares, par value NIS 0.00001SEC:0001628280-26-038069:0
3,430 shares@ US$13.14680.0016% mcap56.1% of flowOrdinary shares, par value NIS 0.00001SEC:0001628280-26-038069:1
228 shares@ US$13.010.0001% mcap50.0% of flowOrdinary shares, par value NIS 0.00001SEC:0001628280-26-035095:0
6 of 6 declarations
